04Mar
HHS Gives New Guidance on Drug Manufacturer Coupons and Out-of-Pocket Maximums
In April 2019, the Department of Health and Human Services (HHS) released guidance indicating that a health plan must include the value of financial assistance received from a drug manufacturer (often referred to as a “coupon” or “copay card”) when...
By:
Foley & Lardner LLP
Related
Join the HUBZone Council as They Celebrate Their 20th Anniversary - On January 17, 2020, the HUBZo...
Read More >
Healthcare Provider Fired Jehovah's Witness for Request to Skip Party, Federal Agency Charges - NE...
Read More >
In today’s highly competitive healthcare environment, investors may find themselves in an auction p...
Read More >
On January 9, 2020, USCIS published a notice in the Federal Register to formally announce the implem...
Read More >
Fortis Advisors LLC v. Allergan W.C. Holding Inc., C.A. No. 2019-0159-MTZ (Del. Ch. May 14, 2020). ...
Read More >
Delaware courts have established rules of construction for interpreting insurance policies. Among th...
Read More >